Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
234.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 11.00 (4.825%)
Market Cap: £74.85m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

8 Aug 2024 17:01

RNS Number : 7974Z
Braemar PLC
08 August 2024
 

 

8 August 2024

BRAEMAR PLC

("Braemar" the "Company")

Director/PDMR Shareholding

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that James Gundy, Group Chief Executive Officer, purchased 10,000 ordinary shares of 10 pence each in the capital of the Company on 8 August 2024. Following this transaction, James Gundy's total shareholding is now 878,574.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

 

For further information, contact:

 

Braemar Plc

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Grant Foley, Group Chief Financial Officer

Rebecca-Joy Wekwete, Company Secretary

 

Buchanan

Charles Ryland / Stephanie Whitmore

Jack Devoy / Abby Gilchrist

Tel +44 (0) 20 7466 5000

Investec Bank plc

Gary Clarence / Alice King

 

Tel +44 (0) 20 7597 5970

Cavendish Securities PLC

Ben Jeynes / Matt Lewis (Corporate Finance)

Leif Powis / Dale Bellis / Charlie Combe (Sales & ECM)

 

 

Tel +44 (0) 20 7220 0500

 

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

James Gundy

 

Reason for the notification

Position/status

 

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10p each

Identification code

 

GB0000600931

Nature of the transaction 

 

Purchase of ordinary shares of 10p each.

Price(s) and volume(s)

Price: £2.9792

 

Volume: 10,000

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £29,792.00

 

Volume: 10,000

Date of the transaction

8 August 2024

 

Place of the transaction 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGGRKRRGDZM
Date   Source Headline
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20252:47 pmRNSGrant of Share Incentives to PDMRs
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20254:15 pmRNSDirector/PDMR Shareholding
2nd Jul 20254:07 pmRNSResults of 2025 Annual General Meeting
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:01 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 202511:11 amRNSInvestigation Update
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20251:42 pmRNSNotice of 2025 Annual General Meeting
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20254:50 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:01 amRNSCommencement of Share Buyback Programme
29th May 20257:00 amRNSFY25 Final Results
20th May 202510:00 amRNS-RInvestor Presentation at Mello London
15th May 20257:00 amRNSNotice of FY25 Results
2nd May 202512:14 pmRNSTotal Voting Rights
1st Apr 20253:43 pmRNSTotal Voting Rights
24th Mar 20257:00 amRNSFY25 Trading Update
7th Mar 20257:00 amRNSDirectorate Change
28th Feb 20259:04 amRNSTotal Voting Rights
31st Jan 20253:14 pmRNSTotal Voting Rights
31st Dec 20247:00 amRNSTotal Voting Rights
17th Dec 202410:23 amRNSHolding(s) in Company
10th Dec 20244:48 pmRNSHolding(s) in Company
10th Dec 20244:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20249:27 amRNSTotal Voting Rights
28th Nov 20244:17 pmRNSPDMR Share Dealing
25th Nov 202411:41 amRNSPDMR Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.